Fund Description
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Israel Capped Investable Market Index (the "underlying index"). The fund will at all times invest at least 90% of its assets in the securities of the underlying index or in depositary receipts representing securities in its underlying index. The underlying index is a custom, free float-adjusted market capitalization index designed to measure broad-based equity market performance in Israel. The underlying index consists of stocks traded primarily on the Tel Aviv Stock Exchange. The fund is non-diversified.
Fund Snapshot Updated 05.22.2013
| Previous Close | $44.47 | Expense Ratio | 0.61% |
| YTD Return | 5.1% | Avg. 30-Day Volume | 20,674 |
| 1-Year Return | 18.0% | Market Cap | Loading... |
| Bid | $44.08 | Shares Outstanding | 1,850,000 |
| Ask | $44.23 | Dividends | $1.04 |
| Top 10 Holdings | |
|---|---|
| Teva Pharma Ind (S:TEVA) | 23.19% |
| Icl-Israel Chem (S:ICL) | 8.83% |
| Bank Hapoalim B.M. (S:POLI) | 8.60% |
| Bk Leumi Le Israel (S:LUMI) | 7.76% |
| Bezeq Israel Telcm (S:BEZQ) | 4.55% |
| Nice Systems (S:NICE) | 4.10% |
| Mellanox Technolog (S:MLNX) | 3.68% |
| Israel Corp (S:ILCO) | 2.65% |
| Israel Discount Bk (S:DSCT) | 2.51% |
| Mizrahi Tefahot Bk (S:MZTF) | 2.47% |
| % of Total Holdings | 68.30% |
